Genomic Health is Going Back in the Black as Positive Earnings Are Now Expected (GHDX) Written on Fri, 02/04/2011 - 4:59am By David Diaz Genomic Health (NASDAQ:GHDX), which was in the red a year ago, is expected to turn a profit this year according to analyst expectations. In the last fiscal year, the company lost $0.33 per share. Genomic Health is now estimated to attain profitability and earn $0.19 per share this year, based on 28.9 million shares outstanding. Genomic Health is currently trading above its 50-day moving average of $21.49 and trading above its 200-day moving average of $16.34. SmarTrend currently has shares of Genomic Health in an Uptrend and issued the Uptrend alert on November 09, 2010 at $17.43. The stock has risen 27.9% since the Uptrend alert was issued.
Today. another Major Diagnostic co. Beckman Coulter received hugh buyout offer from very smart co.DANAHAR at above rumored price. This is next important area for controlling healthcare costs... GHDX is in right area to save unnecessary usage of chemo...drugs for patients with cancer